A61K 31/15
Oximes
Official title: Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) {; Imines (C—N=C)}
A61K31/15 (Oximes) appears on 541 US grants and 741 published applications in this corpus.
Search patents in A61K- Granted patents
- 541
- Published applications
- 741
- Assignees
- 394
- Inventors
- 1,385
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 7 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 15 | 0 |
| 1998 | 25 | 0 |
| 1999 | 13 | 0 |
| 2000 | 11 | 0 |
| 2001 | 20 | 2 |
| 2002 | 15 | 21 |
| 2003 | 14 | 12 |
| 2004 | 6 | 19 |
| 2005 | 3 | 15 |
| 2006 | 6 | 13 |
| 2007 | 3 | 15 |
| 2008 | 5 | 25 |
| 2009 | 5 | 23 |
| 2010 | 6 | 18 |
| 2011 | 9 | 25 |
| 2012 | 8 | 25 |
| 2013 | 14 | 28 |
| 2014 | 13 | 33 |
| 2015 | 21 | 35 |
| 2016 | 25 | 37 |
| 2017 | 27 | 38 |
| 2018 | 25 | 32 |
| 2019 | 16 | 41 |
| 2020 | 31 | 45 |
| 2021 | 34 | 62 |
| 2022 | 33 | 58 |
| 2023 | 20 | 44 |
| 2024 | 24 | 31 |
| 2025 | 23 | 24 |
| 2026 | 5 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same25 Aug 2026US 12,714,704 B2Serina Therapeutics (AL), Inc.
- Combination therapy for the treatment of depression30 Jun 2026US 12,667,724 B2Flow Neuroscience, Inc.
- Small molecules targeting the intrinsically disordered structural ensemble of α-synuclein protect against diverse α-synuclein mediated dysfunctions17 Feb 2026US 12,553,889 B2Dainton Biosciences, LLC
- Method of treating major depressive disorder6 Jan 2026US 12,514,831 B2Clexio Biosciences Ltd.
- Combination therapy for treatment of depression8 Oct 2026US 2026/0306839 A1Flow Neuroscience, Inc.
- Concomitant use of diazoxide in treatment1 Oct 2026US 2026/0294926 A1Soleno Therapeutics, Inc.
- Aldoxime antibiotics and related methods24 Sep 2026US 2026/0283985 A1
- Compounds and combinations thereof for treating neurological and psychiatric conditions24 Sep 2026US 2026/0284039 A1Antecip Bioventures II LLC
- Novel oral dosage form27 Aug 2026US 2026/0248729 A1Neon Healthcare Ltd
Most cited
By later US patents
- Treatment of female sexual dysfunction239US 5,877,216 AVivus, Inc. · 1999
- Treatment of female sexual dysfunction233US 6,294,550 B1Asivi, LLC · 2001
- Treatment of female sexual dysfunction212US 6,306,841 B1Asivi, LLC · 2001
- Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects153US 9,700,528 B2Antecip Bioventures II LLC · 2017
- Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects147US 9,457,023 B1Antecip Bioventures II LLC · 2016